November 14, 2016 Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen: study Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not appear to cause heart problems that spurred the withdrawal of rival Vioxx, according to a large 10-year study presented on Sunday.
November 9, 2016 Internal watchdog told Medicare, Medicaid centers EpiPen was misclassified in 2009 The internal watchdog at the U.S. Department of Health and Human Services warned the office tasked with administering federal health insurance programs that Mylan NV's EpiPen was improperly classified as a generic drug in 2009, Senator Charles Grassley said Tuesday.
November 3, 2016 FDA highlights liver safety issues in Cempra drug review Cempra Inc's experimental drug to treat community acquired pneumonia, the kind suffered by presidential candidate Hillary Clinton recently, causes a potentially concerning rise in liver enzymes, according to a preliminary review by the U.S. Food and Drug Administration.
November 2, 2016 Brexit threatens supply of new drugs, report warns British patients could end up not being able to access modern medicines if there is a "hard Brexit", a think tank report endorsed by a former Conservative health minister warned on Wednesday.
November 1, 2016 Beautiful 'freak' snake may ease your pain one day Ibuprofen for your splitting headache, or venom from the "killer of killers"?
November 1, 2016 Novartis breast cancer drug gets FDA fast track, takes on Pfizer The U.S. Food and Drug Administration gave fast-track review status to Novartis's medication ribociclib in first-line treatment of postmenopausal women with advanced breast cancer as the Swiss company seeks to challenge Pfizer's Ibrance drug.
November 1, 2016 What you need to know about Auvi-Q, the new EpiPen alternative Here's some welcome news for anyone with severe allergies longing for another option besides the famously overpriced EpiPen: Auvi-Q is coming back on the market in the United States in the first half of 2017, according to its maker, Kaléo.
October 31, 2016 Drugmakers turn cheap generics into expensive pills Kendall Jack was dismayed when her health plan stopped covering her migraine drug Treximet earlier this year.
October 28, 2016 5 more charged with drug conspiracy in Middle Tennessee overdose outbreak Five more people are facing federal drug charges in a fentanyl overdose outbreak that killed two people in Tennessee over 24 hours this summer, U.S. Attorney David Rivera announced Thursday.
October 28, 2016 AstraZeneca pauses 2 cancer drug trials' enrollment due to bleeding AstraZeneca's high hopes for cancer immunotherapy were dented on Thursday as the recruitment of new patients with head and neck cancer into two clinical studies was put on hold, following instances of bleeding.